agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
2.550
-0.120 (-4.49%)
At close: May 15, 2025, 4:00 PM
2.580
+0.030 (1.18%)
After-hours: May 15, 2025, 7:56 PM EDT
agilon health Stock Forecast
Stock Price Forecast
According to 17 professional analysts, the 12-month price target for agilon health stock ranges from a low of $2.00 to a high of $9.00. The average analyst price target of $4.59 forecasts a 80.00% increase in the stock price over the next year.
Price Target: $4.59 (+80.00%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 | 2 | 3 |
| Hold | 12 | 13 | 14 | 14 | 13 | 14 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 18 | 19 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +96.08% | May 13, 2025 |
| Barclays | Barclays | Sell Maintains $2 → $3 | Sell | Maintains | $2 → $3 | +17.65% | May 8, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $2.5 → $5 | Hold | Maintains | $2.5 → $5 | +96.08% | May 8, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 28, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $3.25 → $5 | Hold → Strong Buy | Upgrades | $3.25 → $5 | +96.08% | Apr 25, 2025 |
Financial Forecast
Revenue This Year
6.00B
from 6.06B
Decreased by -0.95%
Revenue Next Year
6.64B
from 6.00B
Increased by 10.63%
EPS This Year
-0.36
from -0.63
EPS Next Year
-0.22
from -0.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3B | 7.7B | 9.4B | ||
| Avg | 6.0B | 6.6B | 8.0B | ||
| Low | 5.7B | 5.9B | 6.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.6% | 27.8% | 41.2% | ||
| Avg | -0.9% | 10.6% | 20.0% | ||
| Low | -5.4% | -1.9% | 0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.11 | -0.06 | 0.06 | |
| Avg | -0.36 | -0.22 | -0.12 | |
| Low | -0.46 | -0.31 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.